Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-12

Clinical Trial Update: Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer [NA]

View source ↗

Summary

A clinical trial is investigating using Indocyanine Green (ICG) to identify sentinel lymph nodes during breast cancer surgery. The study status is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Isabelle Henskens | Conditions: Breast Cancer, Sentinel Lymph Node Biopsy (SLNB) | NA | Status: RECRUITING